Clinical trial
A Study to Determine the Clinical Significance of Molecular Detection of Breast…
NCT00355316 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00355316 |
|---|---|
| Title | A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients |
| Official title | Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Other |
| Interventions | Blood draw |
| Enrollment | 224 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2012 |
| Completion | Feb 1, 2013 |
| First posted | Jul 21, 2006 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: